Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving physical activity in patients with Peripheral Artery Disease using electrical stimulation and behavior change

Official title: Motivating Physical Activity With Behavioural interVention and Electrical Stimulation Remotely in People With Intermittent Claudication (MAvERIC): a Feasibility Randomised Controlled Trial

Run by Glasgow Caledonian University · NCT06114732 · Data updated 2026-11-12

This study is testing whether a combination of walking exercises and electrical stimulation can help people with Peripheral Artery Disease be more active and improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment48 (estimated)
SponsorGlasgow Caledonian University
Academic / other
Locations1 site (Glasgow, Lanarkshire)
StatusRecruiting
StartedJanuary 29, 2024
Main results expectedJuly 1, 2026
Study endsDecember 1, 2026
Registry record updatedSeptember 2, 2025
Trial IDNCT06114732 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with symptomatic Peripheral Artery Disease who experience stable Intermittent Claudication and have limited walking ability due to claudication pain.

Probably not a fit

Patients who have critical limb ischemia or those requiring walking aids, such as artificial limbs, are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance physical activity in individuals suffering from Peripheral Artery Disease (PAD) and Intermittent Claudication (IC) through a combination of a walking exercise behavior change intervention and Transcutaneous Electrical Nerve Stimulation (TENS). The approach addresses the challenges faced by patients in accessing supervised exercise programs, particularly in rural areas, by providing a home-based solution that encourages walking despite pain. Participants will be monitored and supported to ensure adherence to the program, which is designed to improve their quality of life and reduce the risks associated with low physical activity levels.

Why it matters

Potential benefit: If successful, this intervention could significantly improve the walking ability and overall quality of life for patients with Peripheral Artery Disease.

How similar studies have gone: Other studies have shown promise in using home-based exercise interventions for similar conditions, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of symptomatic Peripheral Arterial Disease (PAD) including resting ABPI \<0.9 in at least one leg
* Stable IC for ≥3 months
* Walking limited primarily by claudication
* Able to read and speak English to a level allowing satisfactory completion of the study procedures
* Able to provide written informed consent for participation

Exclusion Criteria:

* Planned surgical or endovascular intervention for PAD within the next 3 months
* Critical limb ischaemia
* The presence of any absolute contraindications to exercise testing/training as defined by the American College of Sports Medicine (ACSM)
* Previous experience of using TENS for PAD
* Contraindications to TENS (including epilepsy, dermatological conditions, indwelling electrical pumps/pacemakers) and inability to apply TENS independently.
* Patients who require walking aids including artificial limbs
* Major surgery, myocardial infarction or stroke/ TIA in the previous 6 months
* Co-morbidities that cause pain or limit walking to a greater extent than IC (e.g. severe arthritis, respiratory conditions)
* Severe peripheral neuropathies above the ankle.
* Participation in another research protocol

Where it's running

  • NHS Lanarkshire
    Glasgow, Lanarkshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.